Respiratory Tract Diseases Research
The Lungenfachklinik focuses on pulmonary fibrosis and related interstitial conditions, evaluating new therapies to slow disease progression in patients with a family history of lung scarring.
- Investigation of nerandomilast as an anti‑fibrotic agent
- Assessment of lung function decline in familial cases
- Exploration of biomarkers for interstitial lung disease
With two active trials led by three investigators, the site in Immenhausen, Germany, aims to improve outcomes for individuals suffering from familial pulmonary fibrosis and other interstitial lung diseases.
